Literature DB >> 6980741

Renal handling of 2'-deoxyadenosine and adenosine in humans and mice.

J F Kuttesch, J A Nelson.   

Abstract

In a child lacking adenosine deaminase and in patients treated with deoxycoformycin (a potent inhibitor of the enzyme), apparent renal secretion of 2'-deoxyadenosine (dAdo) and reabsorption of adenosine (Ado) were observed. The renal clearance of dAdo in humans was approximately five-fold that of creatinine, whereas the renal clearance of Ado was only one-fifth that of creatinine. In mice treated with deoxycoformycin, a similar paradigm was observed. Specifically, plasma levels of Ado and dAdo were elevated to detectable levels and apparent renal secretion and reabsorption of these purine nucleosides became manifest. Thus, the mouse may serve as a suitable model to study the renal handling of these two compounds. The active renal secretion of dAdo may occur because the compound has not been appreciably synthesized by mouse kidney in situ, and 'ion-trapping' of dAdo in acid urine could not explain the net secretion. The differential transport of these similar purine nucleosides suggests a very selective transport system in mammalian kidney. Although carrier-mediated, facilitated diffusion of purine nucleosides across cell membranes is a well-known ph enomenon, the present data indicate the existence of (an) active transport system(s) for the transepithelial secretion of dAdo, and possibly for the reabsorption of Ado.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980741     DOI: 10.1007/BF00255488

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  Non-ionic diffusion and the excretion of weak acids and bases.

Authors:  M D MILNE; B H SCRIBNER; M A CRAWFORD
Journal:  Am J Med       Date:  1958-05       Impact factor: 4.965

2.  Evaluation of microparticle chemically bonded reversed-phase packings in the high-pressure liquid chromatographic analysis of nucleosides and their bases.

Authors:  R A Hartwick; P R Brown
Journal:  J Chromatogr       Date:  1976-11-03

3.  Inulin clearance in mice as a standard for radiopharmaceutical bioassay.

Authors:  T Konikowski; T P Haynie; L E Farr
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

4.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

Authors:  J Donofrio; M S Coleman; J J Hutton; A Daoud; B Lampkin; J Dyminski
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

5.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

6.  Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency.

Authors:  G C Mills; R M Goldblum; K E Newkirk; F C Schmalstieg
Journal:  Biochem Med       Date:  1978-10

7.  Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.

Authors:  H A Simmonds; A Sahota; C F Potter; J S Cameron
Journal:  Clin Sci Mol Med       Date:  1978-05

8.  Creatine, creatine and total bodypotassium in relation to muscle mass in children.

Authors:  W P KENNEDY
Journal:  Arch Dis Child       Date:  1961-06       Impact factor: 3.791

9.  Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.

Authors:  R Hirschhorn; V Roegner; A Rubinstein; P Papageorgiou
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Purine metabolism in adenosine deaminase deficiency.

Authors:  G C Mills; F C Schmalstieg; K B Trimmer; A S Goldman; R M Goldblum
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  8 in total

1.  Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles.

Authors:  M Le Hir; U C Dubach
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

2.  Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles.

Authors:  T C Williams; S M Jarvis
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 3.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex.

Authors:  T C Williams; A J Doherty; D A Griffith; S M Jarvis
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

5.  Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney.

Authors:  C M Brett; C B Washington; R J Ott; M M Gutierrez; K M Giacomini
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 6.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 7.  Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.

Authors:  M Pastor-Anglada; E Errasti-Murugarren; I Aymerich; F J Casado
Journal:  J Physiol Biochem       Date:  2007-03       Impact factor: 4.158

8.  Functional expression of the renal organic cation transporter and P-glycoprotein in Xenopus laevis oocytes.

Authors:  J A Nelson; A Dutt; L H Allen; D A Wright
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.